| Literature DB >> 34564175 |
Enqin Xia1, Xuan Zhu1, Xuebin Gao1, Jindong Ni1, Honghui Guo1.
Abstract
Aging is a biological process that occurs under normal conditions and in several chronic degenerative diseases. Bioactive natural peptides have been shown to improve the effects of aging in cell and animal models and in clinical trials. However, few reports delve into the enormous diversity of peptides from marine organisms. This review provides recent information on the antiaging potential of bioactive peptides from underused marine resources, including examples that scavenge free radicals in vitro, inhibit cell apoptosis, prolong the lifespan of fruit flies and Caenorhabditis elegans, suppress aging in mice, and exert protective roles in aging humans. The underlying molecular mechanisms involved, such as upregulation of oxidase activity, inhibition of cell apoptosis and MMP-1 expression, restoring mitochondrial function, and regulating intestinal homeostasis, are also summarized. This work will help highlight the antiaging potential of peptides from underused marine organisms which could be used as antiaging foods and cosmetic ingredients in the near future.Entities:
Keywords: antiaging; mechanism; peptides; underused marine organism
Mesh:
Substances:
Year: 2021 PMID: 34564175 PMCID: PMC8466736 DOI: 10.3390/md19090513
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Marine antiaging peptides and their free radical scavenging activity in vitro.
| Source | Sequences | Activities (EC50) | Ref. |
|---|---|---|---|
| Microorganism | |||
|
| favourzyme hydrolysates | Superoxide3 (0.323 mg/mL), | [ |
| Thr-Met-Glu-Pro-Gly-Lys-Pro | Inhibition of ROS production | [ | |
|
| Ile-Leu-Thr-Lys-Ala-Ala-Ile-Glu-Gly-Lys | DPPH1 | [ |
|
| N-cinnamoyl tripeptide | Hydroxyl2 (equivalent to that of quercetin at 0.1 mM) | [ |
|
| Phe-Glu, Asp-Ile, Ser-Ser-Gln, Leu-Glu | DPPH1 (0.24 mg/mL) | [ |
| Marine invertebrates | |||
|
| Tyr-Ser-Gln-Leu-Glu-Asn-Glu-Phe-Asp-Arg | DPPH1 (0.77 mM) | [ |
| Tyr-Ile-Ala-Glu-Asp-Ala-Glu-Arg | DPPH1 (1.04 mM) | ||
|
| Glu-Met-Gly-Pro-Ala | DPPH1 (0.53 ± 0.02 mg/mL), Hydroxyl2 (0.47 ± 0.03 mg/mL), Superoxide3 (0.75 ± 0.04 mg/mL), ABTS4(0.96 ± 0.08 mg/mL), Inhibition of lipid peroxidation | [ |
| Trp-Pro-Pro-Asp | DPPH1 (0.36 ± 0.02 mg/mL), Hydroxyl1 (0.38 ± 0.04 mg/mL), Superoxide3 (0.46 ± 0.05 mg/mL), ABTS4 (0.54 ± 0.03 mg/mL), Inhibition of lipid peroxidation | ||
|
| Leu-Leu-Gly-Pro-Gly-Leu-Thr-Asn-His-Ala, | DPPH1 (189.8 µM) | [ |
| Asp-Leu-Gly-Leu-Gly-Leu-Pro-Gly-Ala-His | DPPH1 (167.7 µM) | ||
| Fish | |||
| Muscle of | Pro-Glu-Leu-Asp-Trp | DPPH1 (1.53 mg/mL), Hydroxyl2 (1.12 mg/mL), Superoxide2 (0.85 mg/mL), Inhibition of lipid peroxidation, Protection of plasmid DNA | [ |
| Trp-Pro-Asp-His-Trp | DPPH1 (0.70 mg/mL). Hydroxyl2 (0.38 mg/mL) Superoxide3 (0.49 mg/mL). Inhibition of lipid peroxidation, Protect plasmid DNA. | ||
| Phe-Gly-Tyr-Asp-Trp-Trp | DPPH1 (0.53 mg/mL), Hydroxyl2 (0.26 mg/mL), Superoxide3 (0.34 mg/mL). Inhibition of lipid peroxidation, | ||
| Tyr-Leu-His-Phe-Trp | DPPH1 (0.97 mg/mL), Hydroxyl2 (0.67 mg/mL), Superoxide3 (1.37 mg/mL), Inhibit lipid peroxidation. | ||
| Skin of | Pro-Phe-Gly-Pro-Asp | DPPH1 (0.80 mg/mL), Hydroxyl2 (0.81 mg/mL), Superoxide3 (0.91 mg/mL, ABTS4 (0.86 mg/mL), FRAP and Inhibition of lipid peroxidation | [ |
| Pro-Tyr-Gly-Ala-Lys-Gly | DPPH1 (3.02 mg/mL), Hydroxyl2 (0.66 mg/mL), Superoxide3 (0.80 mg/mL), ABTS4 (1.07 mg/mL), FRAP and inhibit lipid peroxidation | ||
| Tyr-Gly-Pro-Met | DPPH1 (0.72 mg/mL), Hydroxyl2 (0.88 mg/mL), Superoxide3 (0.73 mg/mL), ABTS4 (0.82 mg/mL), FRAP and inhibit lipid peroxidation | ||
| Cartilage of | Ile-Glu-Glu-Glu-Gln | DPPH1 (4.61 mg/mL), Hydroxyl2 (0.77 mg/mL), Superoxide3 (0.08 mg/mL), ABTS4 (0.15 mg/mL). | [ |
| Ile-Glu-Pro-His | DPPH1 (1.90 mg/mL,), Hydroxyl2 (0.46 mg/mL), Superoxide3 (0.17 mg/mL), ABTS4 (0.11 mg/mL), Lipid peroxidation inhibition activity. | ||
| Leu-Glu-Glu-Glu-Glu | DPPH1 (3.69 mg/mL), Hydroxyl2 (0.70 mg/mL), Superoxide3 (0.15 mg/mL), ABTS4 (0.19 mg/mL), Fe2+-chelating ability. | ||
| Val-Pro-Arg | DPPH1 (4.01 mg/mL), Hydroxyl2 (1.30 mg/mL), Superoxide3 (0.16 mg/mL), ABTS4 (0.18 mg/mL). | ||
| Head of | Trp-Met-Gly-Pro-Tyr | DPPH1 (0.33 mg/mL), Hydroxyl2 (0.43 mg/mL), Superoxide3 (0.38 mg/mL), FRAP and lipid peroxidation inhibition. | [ |
| Trp-Met-Phe-Asp-Trp | DPPH1 (0.31 mg/mL), Hydroxyl2 (0.30 mg/mL), Superoxide3 (0.56 mg/mL), FRAP and lipid peroxidation inhibition. | ||
| Glu-Met-Gly-Pro-Ala | DPPH1 (0.46 mg/mL), Hydroxyl2 (0.52 mg/mL), Superoxide3 (0.71 mg/mL), FRAP and lipid peroxidation inhibition. | ||
| Salmon gelatin | Gly-Gly-Pro-Ala-Gly-Pro-Ala-Val, Gly-Pro-Val-Ala, Pro-Pro and Gly-Phe | Oxygen radical absorbance capacity (ORAC, 540.94 ± 9.57 µmol TE/g d.w.) | [ |
| Pacific cod skin gelatin | Leu-Leu-Met-Leu-Asp-Asn-Asp-Leu-Pro-Pro | Scavenging the intracellular ROS | [ |
| Jumbo squid ( | Phe-Asp-Ser-Gly-Pro-Ala-Gly-Val-Leu | Inhibition of oxidant stress; Lipid peroxidation inhibition (>Vit. E). | [ |
| Whole body of | Ala-Met-Thr-Gly-Leu-Glu-Ala | DPPH1 (54%), Metal chelating (78.6%) at 1 mg/mL | [ |
| Smooth hound viscera (sharks) | Protein hydrate containing Gly, Glx, Lys, Asx, Arg, Pro and Ala | DPPH1, Inhibition of linoleic acid oxidation, Hydroxyl2. | [ |
| Hoki ( | Glu-Ser-Thr-Val-Pro-Glu-Arg-Thr-His-Pro-Ala-Cys-Pro-Asp-Phe-Asn | DPPH1 (41.37 µM), Hydroxyl2 (17.77 µM), Peroxyl radical scavenging (18.99 µM), Superoxide3 (172.10 µM). | [ |
| Limanda aspera frame | Arg-Pro-Asp-Phe-Asp-Leu-Glu-Pro-Pro-Tyr | Inhibition of linoleic acid autoxidation | [ |
| Tuna backbone | Val-lys-Ala-Gly-Phe-Ala-Trp-Thr-Ala-Asn-Gln-Gln-Leu-Ser | Inhibited lipid peroxidation, Quenched free radicals (DPPH, hydroxyl and superoxide) | [ |
| Frame | Leu-Pro-His-Ser-Gly-Tyr | Hydroxyl2 (35% at 53.6 µM) | [ |
Note: DPPH1-DPPH radical scavenging capacity, Hydroxyl2-Hydroxyl radical scavenging capacity, Superoxide3-Superoxide anion radical scavenging capacity, ABTS4-ABTS cation radical scavenging capacity.
Figure 1Marine peptides intervene in the intrinsic pathway of cell apoptosis (Note: a—scavenging free radical peptides in Table 1, b—Mytilus edulis hydrolysate, and c—peptide from Trapa japonica fruit).
Regulation of gut microbiota by marine peptides.
| Marine Peptides | Test Animal | Improvement of Gut Microbiota | Ref. |
|---|---|---|---|
| Mice | Increase the relative abundance of Bacteroidetes and Actinobacteria | [ | |
| Glycosylated fish protein | Mice | Increase the abundance of | [ |
| Walleye Pollock skin | Mice | Upregulation relative abundance of | [ |
| Skin collagen peptide of | Male rats | Increased abundance of | [ |
| Herring milt hydrolysate (protein: 47–94%) | Mice | Maintain abundant of | [ |
| Peptides from tuna roe | Mice | Short-chain fatty acids production in feces and modulating gut microbiota composition | [ |
| Abalone viscera | Alcohol induced injured mice | Increase in diversity index and the number of Bacilli (class), | [ |
| High-fat diet (HFD)-fed rats | Enriched the abundance of gut beneficial bacteria | [ | |
| Low-calcium diet-fed rats | Improving the abundances of | [ | |
| Oyster polypeptide (OP) fraction | Exhaustive fatigue mice | regulate the abundance of gut microbiota and maintain its balance | [ |